Clinical trial
Observational Cohort Study of Blood Transcriptomics and Proteomics Information as Biomarkers of Traumatic Encephalopathy Syndrome
NCT04928534 is registered in ClinicalTrials.gov with Tianjin Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Cohort Study of Blood Transcriptomics and Proteomics Information as Biomarkers of Traumatic Encephalopathy Syndrome
- Lead sponsor
- Tianjin Medical University
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 1, 2021
- Completion date
- December 1, 2023
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic traumatic encephalopathy, traumatic encephalopathy, chronic, traumatic; encephalopathy, postcontusional